485 related articles for article (PubMed ID: 25827535)
21. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
[TBL] [Abstract][Full Text] [Related]
23. Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: an automated tissue microarray study.
Huang W; Kanehira K; Drew S; Pier T
Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):12-7. PubMed ID: 18769342
[TBL] [Abstract][Full Text] [Related]
24. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma.
Wang HY; Mills SE
Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088
[TBL] [Abstract][Full Text] [Related]
25. Paxillin: application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma.
Kuroda N; Guo L; Toi M; Naruse K; Miyazaki E; Hayashi Y; Yoshikawa C; Ashida S; Shuin T; Enzan H
Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):315-8. PubMed ID: 11759057
[TBL] [Abstract][Full Text] [Related]
26. Nucleophosmin expression in renal cell carcinoma and oncocytoma.
Sari A; Calli A; Altinboga AA; Pehlivan FS; Gorgel SN; Balci U; Ermete M; Dincel C; Cakalagaoglu F
APMIS; 2012 Mar; 120(3):187-94. PubMed ID: 22339675
[TBL] [Abstract][Full Text] [Related]
27. Mutations in the von Hippel-Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma.
Barnabas N; Amin MB; Pindolia K; Nanavati R; Amin MB; Worsham MJ
J Surg Oncol; 2002 May; 80(1):52-60. PubMed ID: 11967908
[TBL] [Abstract][Full Text] [Related]
28. GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics.
Mantilla JG; Antic T; Tretiakova M
Hum Pathol; 2017 Aug; 66():152-158. PubMed ID: 28705707
[TBL] [Abstract][Full Text] [Related]
29. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
Geramizadeh B; Ravanshad M; Rahsaz M
Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
[TBL] [Abstract][Full Text] [Related]
30. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
[TBL] [Abstract][Full Text] [Related]
31. Expression of parafibromin in clear cell papillary renal cell carcinoma.
Cui C; Ziober A; Bing Z
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):322-5. PubMed ID: 23060304
[TBL] [Abstract][Full Text] [Related]
32. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.
Tickoo SK; Amin MB; Linden MD; Zarbo RJ
Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210
[TBL] [Abstract][Full Text] [Related]
33. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ
Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma.
Kuroda N; Kanomata N; Yamaguchi T; Imamura Y; Ohe C; Sakaida N; Hes O; Michal M; Shuin T; Lee GH
Med Mol Morphol; 2011 Jun; 44(2):111-5. PubMed ID: 21717314
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
[TBL] [Abstract][Full Text] [Related]
36. Expression of the EphA1 protein is associated with Fuhrman nuclear grade in clear cell renal cell carcinomas.
Wang X; Liu Y; Cao G; Zhang X; Xu H; Xu H; Wang J
Int J Clin Exp Pathol; 2015; 8(6):6821-7. PubMed ID: 26261568
[TBL] [Abstract][Full Text] [Related]
37. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
[TBL] [Abstract][Full Text] [Related]
38. Immunostaining characteristics of irisin in benign and malignant renal cancers.
Kuloğlu T; Artaş G; Yardim M; Sahin I; Aydin Y; Beyoğlu N; Özercan IH; Yalcin MH; Ugur K; Aydin S
Biotech Histochem; 2019 Aug; 94(6):435-441. PubMed ID: 30896263
[TBL] [Abstract][Full Text] [Related]
39. The expression of heterochromatin protein 1α/β in the kidney tumors: a microarray immunohistochemical study.
Han B; Ziober A; Lu S; Bing Z
Ann Diagn Pathol; 2013 Apr; 17(2):172-5. PubMed ID: 23142018
[TBL] [Abstract][Full Text] [Related]
40. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.
Williamson SR; Eble JN; Amin MB; Gupta NS; Smith SC; Sholl LM; Montironi R; Hirsch MS; Hornick JL
Mod Pathol; 2015 Jan; 28(1):80-94. PubMed ID: 25034258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
